How does trihexyphenidyl affect gastrointestinal tone and motility?

The direct effects on gastrointestinal tone and motility are not detailed for trihexyphenidyl in the source texts. Constipation and dry mouth are listed as peripheral side effects of biperiden, which is pharmacologically similar to trihexyphenidyl.

Why is trihexyphenidyl preferred over atropine in parkinsonism?

Trihexyphenidyl is a central antimuscarinic drug. Unlike atropine, it acts predominantly in the CNS, causing significantly fewer peripheral side effects such as dry mouth or tachycardia.

How does the drug affect the main symptoms of Parkinson's disease?

It effectively reduces tremor and muscle rigidity, but has virtually no effect on bradykinesia.

What is a specific indication for central anticholinergic agents?

Prevention and treatment of drug-induced parkinsonism (extrapyramidal symptoms) caused by antipsychotic therapy.

Why is the drug prescribed with caution in elderly patients?

Elderly patients are highly sensitive to the central side effects of anticholinergics, particularly cognitive impairment (memory loss and reduced concentration).

Home › Pharmacology › Trihexyphenidyl

Trihexyphenidyl

Trihexyphenidylum

For medical students2 min readUpdated 2026-10-10

Trihexyphenidyl is a classic antiparkinsonian agent belonging to the group of central antimuscarinic (anticholinergic) drugs. The drug inhibits excessive cholinergic activity in the basal ganglia, effectively alleviating tremor and muscle rigidity.

Pharmacological classCentral muscarinic receptor antagonists (antiparkinsonian agents)

Mechanism of actionBlockade of M1 muscarinic receptors in the neostriatum

Available formulationsTablets containing 1 mg, 2 mg, and 5 mg

Specific riskAnticholinergic delirium in overdose

Mechanism of Action

Trihexyphenidyl inhibits cholinergic transmission in the central nervous system. Its primary target is the $M_1$ muscarinic receptors of the neostriatum. By blocking these receptors, the drug restores the balance between the dopaminergic and cholinergic systems, which is disrupted in Parkinson's disease. An important pharmacological advantage over classic atropine is that trihexyphenidyl acts predominantly within the CNS, making its peripheral effects significantly weaker.

Pharmacological Effects

The drug exhibits moderate antiparkinsonian activity. Clinically, it primarily and selectively suppresses resting tremor and reduces muscle rigidity (stiffness). A key clinical nuance to keep in mind is that trihexyphenidyl has little effect on bradykinesia (slowness of movement).

Indications

Similar to its congener biperiden, trihexyphenidyl is prescribed for the following extrapyramidal disorders:

Parkinson's disease (primarily in the early stages).
Parkinsonian syndromes of various etiologies.
Drug-induced parkinsonism — a specific indication for this drug class. It is used to prevent and manage extrapyramidal symptoms caused by antipsychotic medications (neuroleptics).

Side Effects and Overdose

Adverse reactions are classified according to their site of action (location of blocked receptors):

Peripheral effects (resulting from peripheral muscarinic receptor blockade): dry mouth (xerostomia), constipation, tachycardia, urinary retention, and cycloplegia (impaired near vision).
Central effects (resulting from central muscarinic receptor blockade): cognitive impairment, including memory loss and poor concentration. Elderly patients are at particularly high risk due to their heightened sensitivity to central adverse effects.

An overdose causes acute psychosis: psychomotor agitation and hallucinations (so-called anticholinergic delirium).

Contraindications

Given its pronounced anticholinergic profile, the drug is strictly contraindicated in:

Glaucoma (due to the risk of increased intraocular pressure).
Prostatic hyperplasia (high risk of acute urinary retention).
Breastfeeding.
Individual hypersensitivity.

Prescribing Guidelines and Dosage

The drug is available in 1 mg, 2 mg, and 5 mg tablets. It is administered orally during meals. The standard single dose is 1–2 mg.

Maximum single dose (MSD): 10 mg.
Maximum daily dose (MDD): 20 mg.

Prescription example: Rp.: Tab. Cyclodoli 0.002 D.t.d. N. 50 S. Take 1 tablet orally with meals.

Mnemonic

Trihexyphenidyl hits the CNS targets: blocks the center (neostriatum), curbs tremor, but fogs memory.

Frequently asked questions

How does trihexyphenidyl affect gastrointestinal tone and motility?: The direct effects on gastrointestinal tone and motility are not detailed for trihexyphenidyl in the source texts. Constipation and dry mouth are listed as peripheral side effects of biperiden, which is pharmacologically similar to trihexyphenidyl.
Why is trihexyphenidyl preferred over atropine in parkinsonism?: Trihexyphenidyl is a central antimuscarinic drug. Unlike atropine, it acts predominantly in the CNS, causing significantly fewer peripheral side effects such as dry mouth or tachycardia.
How does the drug affect the main symptoms of Parkinson's disease?: It effectively reduces tremor and muscle rigidity, but has virtually no effect on bradykinesia.
What is a specific indication for central anticholinergic agents?: Prevention and treatment of drug-induced parkinsonism (extrapyramidal symptoms) caused by antipsychotic therapy.
Why is the drug prescribed with caution in elderly patients?: Elderly patients are highly sensitive to the central side effects of anticholinergics, particularly cognitive impairment (memory loss and reduced concentration).

Go deeper

Comparative profile of trihexyphenidyl and biperiden
Mechanism of drug-induced parkinsonism caused by antipsychotics
Dopamine receptor agonists (e.g., bromocriptine) in parkinsonism therapy
Principles of combination therapy with levodopa and peripheral decarboxylase inhibitors
Anticholinergic toxidrome: clinical presentation and emergency management in overdose